Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS)
India
· Delayed Price · Currency is INR 640.10
+30.45 (4.99%)
Nov 22, 2024, 9:15 AM IST
AKUMS Revenue
Akums Drugs and Pharmaceuticals had revenue of 10.33B INR in the quarter ending September 30, 2024, a decrease of -12.54%. This brings the company's revenue in the last twelve months to 40.83B, up 2.39% year-over-year. In the fiscal year ending March 31, 2024, Akums Drugs and Pharmaceuticals had annual revenue of 41.82B with 14.34% growth.
Revenue (ttm)
40.83B
Revenue Growth
+2.39%
P/S Ratio
2.27
Revenue / Employee
5.53M
Employees
7,388
Market Cap
100.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 41.82B | 5.24B | 14.34% |
| Mar 31, 2023 | 36.57B | -180.32M | -0.49% |
| Mar 31, 2022 | 36.75B | 9.49B | 34.81% |
| Mar 31, 2021 | 27.26B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAkums Drugs and Pharmaceuticals News
- 5 weeks ago - Akums Drugs signs MoU with Zambian Ministry of Health to manufacture local medicine - Business Upturn
- 5 weeks ago - Akums Drugs shares surge 4% after company bags exclusive rights to develop Triple Hair products in India - Business Upturn
- 5 weeks ago - Akums Drugs secures exclusive rights to develop and market Triple Hair products in India - Business Upturn
- 7 weeks ago - McCormick Q3 Earnings Top Estimates, MKC Volumes Improve Y/Y - Benzinga